Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Stats
Total: 71 #1
CompanyConstellation Pharmaceuticals, Inc.
Market Cap372.79MEPS (ttm)-2.95
P/E-EPS this Y-16.80%
Forward P/E-EPS next Y-1.00%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B5.68EPS Q/Q-82.20%
Dividend-Sales Q/Q-
Insider Own0.30%Inst Own81.80%
Insider Trans-Inst Trans0.21%
Short Float2.49%EarningsNov 14/b
Analyst Recom1.60Target Price17.29
Avg Volume122.15K52W Range4.01 - 15.63
Nov-06-19 09:00AMConstellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results GlobeNewswire
Oct-31-19 10:00AMHere's Why Momentum Investors Will Love Constellation Pharmaceuticals, Inc. (CNST) Zacks
Oct-14-19 08:06AMWill Constellation Pharmaceuticals Continue to Surge Higher? Zacks
Oct-10-19 07:00AMConstellation Pharmaceuticals Announces MANIFEST Data Updates Will Be Provided in Oral and Poster Sessions on December 9 at ASH GlobeNewswire
Oct-04-19 08:52AMConstellation Pharmaceuticals (CNST) Looks Good: Stock Adds 8.3% in Session Zacks
Oct-01-19 07:00AMConstellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors GlobeNewswire
Sep-26-19 12:00PMConstellation Pharmaceuticals to Present at Cantor Global Healthcare Conference GlobeNewswire
Sep-24-19 07:00AMConstellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise GlobeNewswire
Sep-23-19 07:17PMInvestors May Want to Follow the Progress of These Biotechs
Aug-21-19 09:00AMConstellation Pharmaceuticals to Participate in Two Investor Conferences GlobeNewswire
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib; and CPI-1205 that is in Phase Ib/II clinical trials for the treatment of metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors. It is also developing CPI-0209, which is in preclinical trials for the treatment of solid tumors. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.
CompanyAgile Therapeutics, Inc.
IndustryDrugs - Generic
Market Cap126.58MEPS (ttm)-0.40
P/E-EPS this Y37.00%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y11.00%
P/S-EPS next 5Y-
P/B4.00EPS Q/Q25.10%
Dividend-Sales Q/Q-
Insider Own0.40%Inst Own42.90%
Insider Trans-91.45%Inst Trans1.00%
Short Float1.25%EarningsNov 07/a
Analyst Recom1.50Target Price4.20
Avg Volume3.48M52W Range0.35 - 2.43
Nov-05-19 06:53AMThe Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment Benzinga
Nov-04-19 11:24AMAgile (AGRX) Stock Surges Over 370%, Whats Next? TipRanks
Oct-31-19 01:11PMAgile Therapeutics' stock rockets nearly 4-fold after contraceptive patch Twirla gets favorable FDA committee nod MarketWatch
Oct-31-19 10:52AMAgile Therapeutics Rallies After FDA Panel Backs Contraceptive Patch Benzinga
Oct-31-19 08:34AMBenzinga Pro's Top 5 Stocks To Watch For Thurs., Oct. 31, 2019: AAPL, FB, AGRX, X, CROX Benzinga
Oct-30-19 06:33PMAgile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15) GlobeNewswire
Oct-29-19 05:24PMAgile (AGRX): Should You Catch this Falling Knife? TipRanks
Oct-29-19 07:32AMThe Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study Benzinga
Oct-28-19 08:00AMAgile Therapeutics Reports Third Quarter 2019 Financial Results GlobeNewswire
Oct-25-19 09:30AMIs Agile Therapeutics (AGRX) Outperforming Other Medical Stocks This Year? Zacks
Agile Therapeutics, Inc., a women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; AG200-ER (SmP), a regimen to allow a woman to extend the length of her cycle, as well as experience shorter and lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerOct 29Sale0.44760,291334,5286,151,110Oct 31 06:30 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 28Sale0.513,815,3491,945,8286,911,401Oct 30 06:31 PM
PERCEPTIVE ADVISORS LLC10% OwnerAug 06Buy0.952,300,0002,185,00010,726,750Oct 30 06:31 PM
ALTOMARI ALFREDChief Executive OfficerJun 10Buy1.2720,00025,400258,568Jun 11 04:30 PM
Lele Abhijeet JDirectorMar 29Buy1.5420,00030,80037,949Apr 01 05:00 PM
TickerAYR [NYSE]
CompanyAircastle Limited
IndustryRental & Leasing Services
Market Cap2.05BEPS (ttm)2.69
P/E10.27EPS this Y72.50%
Forward P/E10.46EPS next Y19.97%
PEG-EPS past 5Y51.20%
P/S2.29EPS next 5Y-0.27%
P/B1.02EPS Q/Q-70.20%
Dividend4.35%Sales Q/Q-41.50%
Insider Own30.85%Inst Own60.30%
Insider Trans-0.04%Inst Trans0.14%
Short Float1.78%EarningsNov 06/b
Analyst Recom3.10Target Price23.30
Avg Volume269.04K52W Range15.75 - 27.74
Nov-06-19 09:25AMAircastle Announces Fourth Quarter 2019 Quarterly Dividend PR Newswire
Nov-06-19 06:48AMUPDATE 2-Aircraft lessor Aircastle to be bought in $2.4 bln deal Reuters
Nov-06-19 06:19AMCORRECTED-Aircraft lessor Aircastle to be acquired in a $2.4 bln deal Reuters
Nov-06-19 06:00AMAircastle Limited Enters into Merger Agreement with Affiliates of Marubeni and Mizuho Leasing PR Newswire
Nov-05-19 05:43PMAirline busts create weakness for leased Boeing 777, Airbus A330 jets American City Business Journals
Oct-30-19 10:33AMAircastle (AYR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-26-19 01:22PMDid Hedge Funds Drop The Ball On Aircastle Limited (AYR) ? Insider Monkey
Oct-24-19 07:38AMAircastle stock jumps premarket after company says it may sell itself MarketWatch
Oct-24-19 07:16AMAircastle Announces Review of Strategic Alternatives PR Newswire
Oct-22-19 04:15PMAircastle to Announce Third Quarter 2019 Earnings on November 6, 2019 PR Newswire
Aircastle Limited, through its subsidiaries, leases, finances, sells, and manages commercial flight equipment to airlines worldwide. As of December 31, 2018, its aircraft portfolio comprised 261 aircraft leased to 81 lessees located in 44 countries. Aircastle Limited was founded in 2004 and is based in Stamford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERRIMAN RONALDDirectorMay 29Sale20.0610,000200,62028,921May 29 04:23 PM
Kriedberg MichaelChief Commercial OfficerMar 31Option Exercise0.0021,0430202,011Apr 02 04:17 PM
Beers Christopher L.Chief Legal OfficerFeb 26Sale20.7215,000310,72579,582Feb 27 05:03 PM
Kriedberg MichaelChief Commercial OfficerFeb 25Sale20.4535,000715,750180,968Feb 26 04:21 PM
CompanyRepro Med Systems, Inc.
IndustryMedical Instruments & Supplies
Market Cap163.51MEPS (ttm)0.00
P/E-EPS this Y0.90%
Forward P/E58.40EPS next Y650.00%
PEG-EPS past 5Y4.00%
P/S8.56EPS next 5Y-
P/B17.52EPS Q/Q-83.70%
Dividend-Sales Q/Q17.80%
Insider Own4.00%Inst Own18.00%
Insider Trans-Inst Trans-
Short Float0.00%Earnings-
Analyst Recom2.00Target Price5.00
Avg Volume48.71K52W Range1.35 - 4.44
Oct-28-19 09:05AMKORU Medical Systems Schedules 2019 Third Quarter Financial Results and Conference Call Business Wire
Oct-25-19 09:15AMKORU Medical Systems to Present Poster Featuring HIgH-Flo Super26 Needle Set at IgNS 2019 National Conference Business Wire
Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
CompanyCross Country Healthcare, Inc.
IndustryStaffing & Outsourcing Services
Market Cap415.98MEPS (ttm)-2.06
P/E-EPS this Y-137.50%
Forward P/E57.91EPS next Y206.25%
PEG-EPS past 5Y23.00%
P/S0.52EPS next 5Y27.57%
P/B2.48EPS Q/Q-
Dividend-Sales Q/Q-0.90%
Insider Own2.70%Inst Own94.80%
Insider Trans0.85%Inst Trans-0.05%
Short Float2.69%EarningsNov 05/a
Analyst Recom2.70Target Price9.70
Avg Volume182.73K52W Range6.75 - 11.54
Nov-05-19 06:35PMCross Country Healthcare (CCRN) Surpasses Q3 Earnings and Revenue Estimates Zacks
Nov-05-19 04:15PMCross Country Healthcare Announces Third Quarter 2019 Financial Results Business Wire
Oct-29-19 10:32AMAnalysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-28-19 04:15PMCross Country Healthcare Announces New $120 Million Senior Credit Facility Business Wire
Oct-23-19 09:15AMLate Selloff Pulls Stocks Lower Zacks
Oct-16-19 02:16PMCross Country Healthcare to Attend the 28th Annual Credit Suisse Healthcare Conference Business Wire
Oct-12-19 09:15AMAre Insiders Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN) Stock? Simply Wall St.
Oct-11-19 10:57AMCross Country Healthcare Announces Third Quarter 2019 Earnings Release Date and Conference Call Information Business Wire
Sep-12-19 07:39AMCross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet Simply Wall St.
Sep-05-19 02:15PMCross Country Healthcare Introduces New Brand Identity for Cejka Executive Search PR Newswire
Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments. It serves public and private acute care and non-acute care hospitals, government facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country Staffing, Mediscan, and DirectEd brands. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Medical Doctor Associates brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The Other Human Capital Management Services segment offers retained and contingent search services for physicians, healthcare executives, nurses, advanced practice, and allied health professionals. Cross Country Healthcare, Inc. was founded in 1996 and is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Clark Kevin CroninPresident, CEOJun 14Buy8.008,33066,640250,734Jun 17 11:50 AM
White Buffy SPres. - Travel Nurse & AlliedNov 13Buy8.252502,06315,180Nov 14 01:15 PM
CompanyInnospec Inc.
IndustrySpecialty Chemicals
Market Cap2.24BEPS (ttm)4.23
P/E21.78EPS this Y-5.40%
Forward P/E16.86EPS next Y9.34%
PEG2.90EPS past 5Y4.20%
P/S1.49EPS next 5Y7.50%
P/B2.62EPS Q/Q1.50%
Dividend1.08%Sales Q/Q1.20%
Insider Own0.30%Inst Own95.60%
Insider Trans-9.09%Inst Trans-0.38%
Short Float1.38%EarningsNov 05/a
Analyst Recom2.30Target Price102.50
Avg Volume113.52K52W Range53.07 - 97.18
Nov-05-19 04:45PMInnospec Reports Third Quarter 2019 Financial Results GlobeNewswire
Nov-05-19 08:00AMDid Business Growth Power Innospec's (NASDAQ:IOSP) Share Price Gain of 109%? Simply Wall St.
Oct-26-19 09:41PMWere Hedge Funds Right About Selling Innospec Inc. (IOSP)? Insider Monkey
Oct-21-19 10:47AMHow Should Investors Feel About Innospec Inc.'s (NASDAQ:IOSP) CEO Pay? Simply Wall St.
Oct-17-19 04:45PMInnospec Publishes 2018 Responsible Business Report GlobeNewswire
Oct-08-19 04:45PMInnospec Schedules Third Quarter 2019 Earnings Release and Conference Call GlobeNewswire
Oct-04-19 10:50AMWhat Can We Make Of Innospec Inc.s (NASDAQ:IOSP) High Return On Capital? Simply Wall St.
Sep-30-19 04:45PMInnospec Closes on New $250 Million Credit Facility GlobeNewswire
Sep-19-19 02:04PMCan Innospec Inc. (NASDAQ:IOSP) Improve Its Returns? Simply Wall St.
Sep-04-19 11:58AMWhat Does Innospec Inc.'s (NASDAQ:IOSP) Share Price Indicate? Simply Wall St.
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in environmental remediation business that manages the cleanup of redundant TEL facilities. The company sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction preparations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watt BrianVP, Strat Plan & RegulatoryAug 22Sale84.163,000252,47427,888Aug 23 10:00 AM
HESSNER CATHERINESenior VP - Human ResourcesJun 04Sale83.642,000167,27220,000Jun 05 03:22 PM
Curran PhilipGroup Financial ControllerJun 04Sale83.1230024,9361,993Jun 05 03:24 PM
Watt BrianVP, Strat Plan & RegulatoryMay 30Sale82.012,000164,01830,888May 31 03:22 PM
Aldous HughDirectorMay 29Option Exercise28.283,18289,99321,147May 30 05:58 PM
TickerVEC [NYSE]
CompanyVectrus, Inc.
IndustryBusiness Services
Market Cap537.54MEPS (ttm)2.86
P/E16.24EPS this Y34.40%
Forward P/E11.97EPS next Y30.10%
PEG-EPS past 5Y-18.30%
P/S0.42EPS next 5Y-
P/B2.22EPS Q/Q-18.70%
Dividend-Sales Q/Q3.30%
Insider Own1.30%Inst Own88.00%
Insider Trans-0.66%Inst Trans1.33%
Short Float0.94%EarningsNov 05/a
Analyst Recom2.70Target Price47.00
Avg Volume70.12K52W Range19.61 - 47.45
Nov-06-19 04:08AMEdited Transcript of VEC earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-05-19 07:05PMVectrus (VEC) Tops Q3 Earnings and Revenue Estimates Zacks
Nov-05-19 04:05PMVectrus Announces Strong Third Quarter 2019 Results PR Newswire
Oct-31-19 04:27PMVectrus Recognized as Top Military Friendly Employer PR Newswire
Oct-29-19 10:32AMEarnings Preview: Vectrus (VEC) Q3 Earnings Expected to Decline Zacks
Oct-24-19 02:48PMWhat Kind Of Share Price Volatility Should You Expect For Vectrus, Inc. (NYSE:VEC)? Simply Wall St.
Oct-22-19 05:11PMVectrus to Announce Third Quarter 2019 Results PR Newswire
Oct-11-19 03:52PMScott Black's New Buys for the 3rd Quarter
Oct-03-19 03:51PMWhy We Like Vectrus, Inc.s (NYSE:VEC) 14% Return On Capital Employed Simply Wall St.
Sep-13-19 12:41PMIs Vectrus, Inc.'s (NYSE:VEC) 14% ROE Strong Compared To Its Industry? Simply Wall St.
Vectrus, Inc. provides facility and logistics, and information technology and network communication services to the U.S. government worldwide. The company offers facility and logistics services, such as airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, warehouse management and distribution, and equipment maintenance, repair, and services for U.S. Army, Air Force, Navy, and Marines. It also provides information technology and network communication services, including sustainment of communications systems, network security, systems installation, and full life cycle management of information technology systems, system-of-systems engineering and software development, and mission support for the Department of Defense. The company was incorporated in 2014 and is headquartered in Colorado Springs, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boyle Kevin TSVP, CLO & General CounselOct 22Option Exercise0.001,44901,949Oct 24 07:16 PM
Hathaway DavidSVP, ProgramsOct 17Option Exercise0.001,38503,167Oct 18 06:43 PM
Murdy William FDirectorSep 09Sale41.431,00041,43115,671Sep 10 06:24 PM
PILLMORE ERIC MDirectorMay 15Option Exercise0.003,669021,671May 17 04:59 PM
HOWELL MARY LDirectorMay 15Option Exercise0.003,669018,411May 17 05:02 PM
TickerABR [NYSE]
CompanyArbor Realty Trust, Inc.
IndustryREIT - Diversified
Market Cap1.31BEPS (ttm)1.39
P/E10.30EPS this Y42.30%
Forward P/E11.03EPS next Y2.69%
PEG1.29EPS past 5Y31.00%
P/S2.51EPS next 5Y8.00%
P/B1.44EPS Q/Q21.00%
Dividend8.10%Sales Q/Q3.50%
Insider Own1.60%Inst Own55.90%
Insider Trans0.46%Inst Trans-0.06%
Short Float13.82%EarningsNov 01/b
Analyst Recom2.80Target Price13.45
Avg Volume1.06M52W Range9.48 - 14.32
Nov-06-19 09:14AMThe Extreme Risks of Trading Your Own Retirement Assets - November 06, 2019 Zacks
Nov-05-19 04:05PMArbor Realty Trust, Inc. Announces Proposed Private Offering of Convertible Senior Notes due 2022 GlobeNewswire
Nov-05-19 09:49AMPowerful Proof Anyone Can Invest for an Early Retirement - November 05, 2019 Zacks
Nov-05-19 09:41AMThe Truth About Market Timing - November 05, 2019 Zacks
Nov-03-19 11:40PMEdited Transcript of ABR earnings conference call or presentation 1-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Nov-01-19 11:35AMWasatch Small Cap Value Holds Its Head Up Kiplinger
Nov-01-19 09:25AMArbor Realty Trust (ABR) Q3 FFO Beat Estimates Zacks
Nov-01-19 08:15AMArbor Realty Trust Reports Third Quarter 2019 Results and Increases Quarterly Dividend to $0.30 per Share GlobeNewswire
Oct-31-19 12:15PMKey Factors to Impact Arbor Realty's (ABR) Q3 Earnings Zacks
Oct-27-19 03:58PMIs Arbor Realty Trust, Inc. (ABR) A Good Stock To Buy? Insider Monkey
Arbor Realty Trust, Inc. invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets. The company operates in two segments, Structured Business and Agency Business. It primarily invests in real estate-related bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related notes and various mortgage-related securities. The company offers bridge financing products to borrowers who seek short-term capital to be used in an acquisition of property; financing by making preferred equity investments in entities that directly or indirectly own real property; mezzanine financing in the form of loans that are subordinate to a conventional first mortgage loan and senior to the borrower's equity in a transaction; and junior participation financing in the form of a junior participating interest in the senior debt. In addition, it underwrites, originates, sells, and services multifamily mortgage loans. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2003 and is headquartered in Uniondale, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green William CDirectorSep 16Buy12.8320,000256,599121,465Sep 18 05:30 PM
Green William CDirectorSep 16Sale12.8017,793227,836103,672Sep 18 05:30 PM
LAZAR MELVIN FDirectorAug 14Buy12.164,55955,433205,000Aug 14 04:15 PM
KAUFMAN IVANCOB, CEO and PresidentFeb 13Option Exercise0.00445,76501,208,446Feb 15 04:31 PM
TickerAER [NYSE]
CompanyAerCap Holdings N.V.
IndustryAir Services, Other
Market Cap7.97BEPS (ttm)7.50
P/E7.87EPS this Y4.00%
Forward P/E7.86EPS next Y-4.46%
PEG1.25EPS past 5Y21.80%
P/S1.69EPS next 5Y6.30%
P/B0.89EPS Q/Q42.20%
Dividend-Sales Q/Q5.20%
Insider Own12.24%Inst Own99.01%
Insider Trans0.00%Inst Trans-2.77%
Short Float1.48%EarningsNov 08/b
Analyst Recom2.20Target Price66.82
Avg Volume798.77K52W Range36.16 - 59.99
Nov-05-19 05:43PMAirline busts create weakness for leased Boeing 777, Airbus A330 jets American City Business Journals
Nov-04-19 09:37AM5 Best Stocks To Buy Right Now According To Billionaire Einhorn Insider Monkey
Nov-01-19 10:30AMAerCap (AER) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-23-19 07:00AMAerCap Holdings N.V. Announces Completion of Amendment and Extension of Unsecured Revolver PR Newswire
Oct-23-19 06:01AMWhat AerCap Holdings N.V.'s (NYSE:AER) ROE Can Tell Us Simply Wall St.
Oct-22-19 07:00AMAerCap Delivers a New Boeing 787-9 Dreamliner to Air New Zealand PR Newswire
Oct-15-19 11:03AMWere Hedge Funds Right About Warming Up To AerCap Holdings N.V. (AER) ? Insider Monkey
Oct-14-19 07:00AMAerCap Leased, Purchased and Sold 108 Aircraft in the Third Quarter 2019 PR Newswire
Oct-09-19 03:01PMAerCap picks up Airbus jet orders dropped by Norwegian - sources Reuters
Oct-09-19 09:10AMIs AerCap (AER) a Great Value Stock Right Now? Zacks
AerCap Holdings N.V., an aircraft leasing company, engages in the lease, financing, sale, and management of commercial aircraft and engines in China, the United States, Ireland, and internationally. The company offers aircraft asset management services, including remarketing aircraft; collecting rental and maintenance rent payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft; and conducting ongoing lessee financial performance reviews. Its aircraft asset management services also comprise periodically inspecting the leased aircraft; coordinating technical modifications to aircraft to meet new lessee requirements; conducting restructuring negotiations in connection with lease defaults; repossessing aircraft; arranging and monitoring insurance coverage; registering and de-registering aircraft; arranging for aircraft and aircraft engine valuations; and providing market research services. The company also provides cash management services, including treasury services, such as the financing, refinancing, hedging, and ongoing cash management of vehicles; and administrative services comprising accounting and corporate secretarial services consisting of the preparation of budgets and financial statements. As of December 31, 2018, it had a portfolio of 1,421 owned, managed, or on order aircraft. AerCap Holdings N.V. was founded in 1995 and is headquartered in Dublin, Ireland.
CompanyLuna Innovations Incorporated
IndustryScientific & Technical Instruments
Market Cap170.68MEPS (ttm)0.08
P/E70.36EPS this Y159.60%
Forward P/E26.86EPS next Y15.79%
PEG-EPS past 5Y15.70%
P/S3.00EPS next 5Y-
P/B2.56EPS Q/Q197.90%
Dividend-Sales Q/Q79.80%
Insider Own11.00%Inst Own30.30%
Insider Trans-29.04%Inst Trans-2.03%
Short Float0.73%EarningsNov 05/a
Analyst Recom1.70Target Price7.00
Avg Volume303.86K52W Range2.68 - 6.90
Nov-06-19 02:07AMEdited Transcript of LUNA earnings conference call or presentation 5-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-05-19 04:05PMLuna Innovations Reports Strong Third-Quarter 2019 Results Business Wire
Oct-29-19 08:30AMLuna Selected as a NASA Partner for Moon and Mars Technologies Business Wire
Oct-28-19 01:54PMShareholders Are Raving About How The Luna Innovations (NASDAQ:LUNA) Share Price Increased 354% Simply Wall St.
Oct-22-19 08:40AMLuna Announces Third-Quarter 2019 Financial Release Date of November 5, 2019 GlobeNewswire
Oct-15-19 08:30AMLuna Announces New Credit Facility Business Wire
Sep-26-19 08:00AMLuna Innovations Announces Conversion of Preferred Shares Business Wire
Sep-20-19 08:41AMIs Luna Innovations Incorporated's (NASDAQ:LUNA) 4.9% ROE Worse Than Average? Simply Wall St.
Sep-12-19 08:30AMLunas Fiber Optic Sensing Products Enhance the Safety of Oil and Gas Pipelines Business Wire
Sep-10-19 08:30AMLuna Innovations to Present at Singular Research Midwestern Values Conference on September 19, 2019 Business Wire
Luna Innovations Incorporated develops, manufactures, and markets fiber optic sensing, and test and measurement products worldwide. It operates in two segments, Products and Licensing, and Technology Development. The Products and Licensing segment offers test and measurement products, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; optical distributed sensor interrogator sensing solutions for distributed strain and temperature measurements; and Hyperion sensing solution that enable full-spectrum data acquisition and flexible peak detect algorithms of fiber-bragg grating (FBG), long period FBGs and fabry-perot sensors with low-latency access to data for closed loop feedback applications. This segment also provides general photonics comprising components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and TeraMetrix products to measure and verify physical properties online and in real-time to reduce raw materials and rework costs in manufacturing processes as well as to conduct quality control monitoring utilizing terahertz measurement technologies. The Technology Development segment provides applied research for customers principally in the areas of sensing and instrumentation, advanced materials, and health sciences. The company sells its products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was founded in 1990 and is headquartered in Roanoke, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROEDEL RICHARDDirectorSep 13Option Exercise0.6160,00036,600177,573Sep 17 04:56 PM
Carilion Clinic10% OwnerSep 06Sale6.7051,047342,015864,330Sep 06 05:02 PM
Carilion Clinic10% OwnerSep 05Sale6.7148,953328,475915,377Sep 06 05:02 PM
Carilion Clinic10% OwnerSep 04Sale6.3271,701453,150964,330Sep 06 05:02 PM
Carilion Clinic10% OwnerSep 03Sale6.3983,634534,4211,036,031Sep 04 04:53 PM
1 2 3 4 5 6 7 8 next